UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adequacy of implantable cardioverter-defibrillator lead placement for tachyarrhythmia detection by sinus rhythm electrogram amplitude

The American journal of cardiology, 1995-12, Vol.76 (16), p.1162-1166

1995

Volltextzugriff (PDF)

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis

European journal of heart failure, 2012-05, Vol.14 (5), p.473-479

2012

Volltextzugriff (PDF)

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula

Circulation. Heart failure, 2012-05, Vol.5 (3), p.309-314

2012

Volltextzugriff (PDF)

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

European heart journal, 2015-05, Vol.36 (18), p.1106-1114

2015

Volltextzugriff (PDF)

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

European journal of heart failure, 2015-11, Vol.17 (11), p.1182-1191

2015

Volltextzugriff (PDF)

Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report

European journal of heart failure, 2013-11, Vol.15 (11), p.1220-1227

2013

Volltextzugriff (PDF)

Methods for the Measurement of Platelet Function

The American journal of cardiology, 2009-02, Vol.103 (3), p.20A-26A

Michelson, Alan D., MD

2009

Volltextzugriff (PDF)

Platelet function testing in cardiovascular diseases

Circulation (New York, N.Y.), 2004-11, Vol.110 (19), p.e489-e493

Michelson, Alan D

2004

Volltextzugriff (PDF)

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Circulation (New York, N.Y.), 2005-12, Vol.112 (24), p.3738-3744

2005

Volltextzugriff (PDF)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

European journal of heart failure, 2014-01, Vol.16 (1), p.33-40

2014

Volltextzugriff (PDF)

Platelet Function Monitoring in Patients With Coronary Artery Disease

Journal of the American College of Cardiology, 2007-11, Vol.50 (19), p.1822-1834

2007

Volltextzugriff (PDF)

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

The American heart journal, 2011-11, Vol.162 (5), p.900-906

2011

Volltextzugriff (PDF)

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Journal of the American College of Cardiology, 2013-02, Vol.61 (8), p.872-879

2013

Volltextzugriff (PDF)

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Journal of the American College of Cardiology, 2012-04, Vol.59 (14), p.1304-1311

2012

Volltextzugriff (PDF)

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.671-678

2006

Volltextzugriff (PDF)

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin : Studies in baboons, human coronary intervention, and human acute myocardial infarction

Circulation (New York, N.Y.), 2001-09, Vol.104 (13), p.1533-1537

2001

Volltextzugriff (PDF)

Novel Antiplatelet Agents in Cardiovascular Disease

Journal of Cardiovascular Pharmacology and Therapeutics, 2020-05, Vol.25 (3), p.191-200

2020

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Journal of the American College of Cardiology, 2007-07, Vol.50 (1), p.40-47

2007

Volltextzugriff (PDF)

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Circulation (New York, N.Y.), 2007-09, Vol.116 (13), p.1482-1487

2007

Volltextzugriff (PDF)

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

European journal of heart failure, 2009-02, Vol.11 (2), p.170-177

2009

Volltextzugriff (PDF)

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1785-1795

2012

Volltextzugriff (PDF)

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1997-2004

2006

Volltextzugriff (PDF)

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-06, Vol.115 (24), p.3111-3120

2007

Volltextzugriff (PDF)

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

European heart journal, 2011-04, Vol.32 (7), p.838-846

2011

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Aktive Filter

ThemaCardiac & Cardiovascular Systems

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(195)

Publikationsform

Artikel
(201)

Sprache

Englisch
(201)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(201)
Life Sciences & Biomedicine
(201)
Science & Technology
(201)
Humans
(141)
Male
(96)
Female
(89)
Biological And Medical Sciences
(79)
Medical Sciences
(73)
Middle Aged
(72)
Aged
(61)
Peripheral Vascular Disease
(56)
Cardiology. Vascular System
(53)
Animals
(44)
Heart
(39)
Heart Failure
(35)
Adult
(34)
Electrocardiography
(32)
Dogs
(30)
Kardiologi
(30)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adequacy of implantable cardioverter-defibrillator lead placement for tachyarrhythmia detection by sinus rhythm electrogram amplitude

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report

Methods for the Measurement of Platelet Function

Platelet function testing in cardiovascular diseases

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Platelet Function Monitoring in Patients With Coronary Artery Disease

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin : Studies in baboons, human coronary intervention, and human acute myocardial infarction

Novel Antiplatelet Agents in Cardiovascular Disease

Predictors of mortality and morbidity in patients with chronic heart failure

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

Aktive Filter

Suchergebnisse filtern